Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 31.97M
March 31, 2026 30.75M
December 31, 2025 -10.31M
September 30, 2025 -38.79M
June 30, 2025 -33.18M
March 31, 2025 4.435M
December 31, 2024 14.21M
September 30, 2024 13.88M
June 30, 2024 21.92M
March 31, 2024 25.83M
December 31, 2023 30.92M
September 30, 2023 28.10M
June 30, 2023 16.82M
March 31, 2023 18.37M
December 31, 2022 24.86M
September 30, 2022 35.01M
June 30, 2022 57.40M
March 31, 2022 64.87M
Date Value
December 31, 2021 61.98M
September 30, 2021 67.24M
June 30, 2021 48.26M
March 31, 2021 21.27M
December 31, 2020 5.466M
September 30, 2020 -24.15M
June 30, 2020 -38.47M
March 31, 2020 -41.25M
December 31, 2019 -33.53M
September 30, 2019 -87.14M
June 30, 2019 -81.98M
March 31, 2019 -70.07M
December 31, 2018 -60.74M
September 30, 2018 -0.815M
June 30, 2018 -0.697M
March 31, 2018 -0.6867M
December 31, 2017 -0.5866M
September 30, 2017 -0.487M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
cbdMD, Inc. -2.218M
Guardian Pharmacy Services, Inc. 98.86M
ACADIA Pharmaceuticals, Inc. 160.32M
Agenus, Inc. -98.50M
Alnylam Pharmaceuticals, Inc. 885.89M